This supportive study evaluating the contraceptive efficacy of Sino-implant (II) in women shows the product to be highly effective over five years. The World Health Organization prequalified Sino-implant (II), now marketed globally as Levoplant, as a three-year contraceptive method in June 2017, resulting in the distribution of more than one million units in the following year.
Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China
Written By
Che Y, Taylor D, Luo D, Maldonado LY, Wang M, Wevill S, Vahdat H, Han X, Halpern V, Dorflinger L, Steiner MJ
